By comparing the two ROC curves, MFG-E8 shows slightly better predictive capability than CTGF, but neither is sufficient on its own to predict the 28-day mortality outcome in SCAP patients. The gene discussed is CCN2; the disease is syringocystadenoma papilliferum.